Antiplatelet loading improves behavioral outcome in a rabbit model of stroke

Stroke

Volumn 44, Issue 11, 2013, Pages 3246-3248

  Meyer, Dawn M ^a,b   Compton, Peggy ^b   Eastwood, Jo Ann ^b   Gylys, Karen ^b   Zivin, Justin A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Animal; Antiplatelet drugs; Models; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; CLOPIDOGREL; COLLAGEN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULANT THERAPY; ARTICLE; ARTIFICIAL EMBOLISM; BEHAVIOR DISORDER; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; LOADING DRUG DOSE; MALE; MIDDLE CEREBRAL ARTERY; NEUROLOGIC DISEASE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RABBIT MODEL; THROMBOCYTE AGGREGATION;

ANTIPLATELET DRUGS; MODELS, ANIMAL; STROKE;

ADENOSINE DIPHOSPHATE; ANIMALS; ARACHIDONIC ACID; ASPIRIN; BLOOD PLATELETS; BRAIN ISCHEMIA; COLLAGEN; DISEASE MODELS, ANIMAL; EMBOLIZATION, THERAPEUTIC; FIBRINOLYTIC AGENTS; MALE; PLATELET AGGREGATION INHIBITORS; RABBITS; RANDOM ALLOCATION; TREATMENT OUTCOME;

EID: 84888289689     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.002565     Document Type: Article

References (10)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1588.
2. Meyer DM, Albright KC, Allison TA, Grotta JC. LOAD: a pilot study of the safety of loading of aspirin and clopidogrel in acute ischemic stroke and transient ischemic attack. J Stroke Cerebrovasc Dis. 2008;17:26-29.
3. Wang Y, Wang Y, Zhao X, Liu L, Wang D, Wang C, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013;369:11-19.
4. POINT Investigators. Platelet oriented inhibition in new TIA and minor ischemic stroke (POINT) trial. http://www.pointtrial.org/. Accessed January 26, 2013.
5. Zivin JA, DeGirolami U. A new approach in the experimental investigation of stroke. Trans Am Neurol Assoc. 1980;105:161-172.
6. Zivin JA, Fisher M, DeGirolami U, Hemenway CC, Stashak JA. Tissue plasminogen activator reduces neurological damage after cerebral embolism. Science. 1985;230:1289-1292.
7. Lapchak PA, Araujo DM, Song D, Wei J, Zivin JA. Neuroprotective effects of the spin trap agent NXY-059 in a rabbit small clot embolic stroke model: combination studies with the thrombolytic tissue plasminogen activator. Stroke. 2002;33:1411-1415.
8. Lapchak PA. Development of thrombolytic therapy for stroke: a perspective. Expert Opin Investig Drugs. 2002;11:1623-1632.
9. Born GV. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 1962;194:927-929.
10. Jauch EC, Saver JL, Adams HP, Bruno A, Connors JJ, Demaerschalk BM, et al. Guidelines for the early management of patients with acute ischemic stroke. Stroke. 2013;44:870-947.